In Vitro Activities of Polycationic Peptides Alone and in Combination with Clinically Used Antimicrobial Agents against Rhodococcus equi | Zendy

Andrea Giacometti | Zendy; Oscar Cirioni | Zendy; F. Ancarani | Zendy; Maria Simona Del Prete | Zendy; M. Fortuna | Zendy; Giorgio Scalise | Zendy

Open Access

In Vitro Activities of Polycationic Peptides Alone and in Combination with Clinically Used Antimicrobial Agents against Rhodococcus equi

Author(s) -

Andrea Giacometti,

Oscar Cirioni,

F. Ancarani,

Maria Simona Del Prete,

M. Fortuna,

Giorgio Scalise

Publication year - 1999

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.43.8.2093

Subject(s) - rhodococcus equi , antimicrobial , nisin , microbiology and biotechnology , clarithromycin , vancomycin , magainin , ampicillin , linezolid , rifabutin , antibiotics , biology , in vitro , bacteria , antimicrobial peptides , staphylococcus aureus , biochemistry , genetics , virulence , gene

The in vitro activities of magainin II, nisin, and ranalexin alone and in combination with other antimicrobial agents against six clinical isolates of Rhodococcus equi were investigated by MIC and time-kill studies. All isolates were more susceptible to nisin. A positive interaction was observed when the peptides were combined with ampicillin, ceftriaxone, rifabutin, rifampin, azithromycin, clarithromycin, and vancomycin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research